Parvovirus H-1 (Oryx)
N/A
Report date: 2023/05/01 20:00:20
Base Information
Drug NameParvovirus H-1 (Oryx)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOryx Gmbh & Co
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A